Keywords: تعامل دارو و دارو; AOX; aldehyde oxidase; AUC; area under the plasma concentration time curve; CYP; cytochrome P450; DDI; drug-drug interaction; LC; liquid chromatography; MBE; minimum binding energy; MS/MS; tandem mass spectrometry; ESI; electrospray ionization; PK; phar
مقالات ISI تعامل دارو و دارو (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تعامل دارو و دارو; antiretroviral agent; combination antiretroviral therapy; drug-drug interaction; nucleoside reverse-transcriptase inhibitor; protease inhibitor;
Keywords: تعامل دارو و دارو; Acyl glucuronide; Drug development; Drug toxicity; In vitro screening; In vivo model; Immune activation; Protein adduct; Reactive metabolite; UDP-glucuronosyltransferase; ADR; adverse drug reaction; AG; acyl glucuronide; AGE; advanced glycation end prod
Keywords: تعامل دارو و دارو; drug interaction; cytochrome P450s; membrane transport/transporters; substrate; inhibitor; inducer; AE; adverse event; CYP; cytochrome P-450; DDI; drug-drug interaction; E-R; exposure-response; FDA; Food and Drug Administration; PK; pharmacokinetic;
Keywords: تعامل دارو و دارو; Mirabegron; Tolterodine; Drug-drug interaction; Pharmacokinetics and drug metabolism; Overactive bladder; Japanese;
Keywords: تعامل دارو و دارو; in silico modeling; QSAR; transporters; computational ADME; high-throughput technologies; AUC; area under the curve; BCRP; breast cancer resistance protein; DDI; drug-drug interaction; fup; protein unbound fraction in plasma; ITC; International Transpor
Keywords: تعامل دارو و دارو; AUC; area under the plasma concentration-time curve; B/P; blood-to-plasma ratio; CYP; cytochrome P450; CLint; intrinsic clearance; Cmax; maximum plasma concentration; CLPD; passive permeability-surface area product; DDI; drug-drug interaction; fa; fract
Keywords: تعامل دارو و دارو; Drug-drug interaction; Biomedical literature; Linear kernel approach;
Keywords: تعامل دارو و دارو; Marine mussel; Fluoxetine; Propranolol; Bioaccumulation; Biomarkers; Lysosomal responses; Drug-drug interaction; Adverse outcome pathway;
Keywords: تعامل دارو و دارو; Drug-drug interaction; Record linkage; Natural language processing; Pharmacovigilance;
Keywords: تعامل دارو و دارو; Clopidogrel; Drug-drug interaction; Dual antiplatelet therapy; Platelet reactivity;
Keywords: تعامل دارو و دارو; Drug-drug interaction; Anthelmintic resistance; Combined formulations; Sheep;
Keywords: تعامل دارو و دارو; ADMET; absorption, distribution metabolism, elimination, toxicity; API; active pharmaceutical ingredient; BS; bilesalt; BS/PL; bile salt to phospholipid ratio; CMC; critical micellar concentration; DDI; drug-drug interaction; FaSSGF; fasted state simula
Keywords: تعامل دارو و دارو; Drug-drug interaction; Nephroprotective; Rhei rhizoma; SLC22A6; SLC22A8; Solute carrier;
Keywords: تعامل دارو و دارو; diabetes; DPP-4 inhibitor; drug-drug interaction; empagliflozin; linagliptin; SGLT2 inhibitor;
Clustering based drug-drug interaction networks for possible repositioning of drugs against EGFR mutations: Clustering based DDI networks for EGFR mutations
Keywords: تعامل دارو و دارو; Clustering; Drug-drug interaction; EGFR; Lipinski rule; Repositioning;
P-gp is involved in the intestinal absorption and biliary excretion of afatinib in vitro and in rats
Keywords: تعامل دارو و دارو; AUC; area under the plasma concentration-time curve; BEI; biliary excretion index; CsA; cyclosporin A; DDI; drug-drug interaction; LC-MS/MS; liquid chromatography-tandem mass spectrometry; MDCKII cells; Madin-Darby canine kidney strain II cells; N
Influence of proton pump inhibitors on blood dabigatran concentrations in Japanese patients with non-valvular atrial fibrillation
Keywords: تعامل دارو و دارو; Dabigatran; Proton pump inhibitor; Drug-drug interaction;
Lacosamide and concomitant use of antiepileptic and other medications in a US population - A retrospective cohort study
Keywords: تعامل دارو و دارو; Claims; Comorbidities; Drug-drug interaction; MarketScan; Epilepsy; Prescription;
Computational study of the competitive binding of valproic acid glucuronide and carbapenem antibiotics to acylpeptide hydrolase
Keywords: تعامل دارو و دارو; Homology modeling; Docking simulation; Fragment molecular orbital calculation; Valproic acid; Carbapenem; Drug-drug interaction;
Increase in the systemic exposure of primary metabolites of Midazolam in rat arising from CYP inhibition or hepatic dysfunction
Keywords: تعامل دارو و دارو; Midazolam; Primary metabolites; Systemic exposure; Drug-drug interaction; CYP inhibition; Acute hepatitis;
Original ArticlePharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508DEL-CFTR
Keywords: تعامل دارو و دارو; AE; adverse event; AUC; area under the curve; BID; twice daily; CF; cystic fibrosis; CFQ-R; Cystic Fibrosis Questionnaire-Revised; CFTR; cystic fibrosis transmembrane conductance regulator; DDI; drug-drug interaction; ECG; electrocardiogram; ER; endopla
Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia
Keywords: تعامل دارو و دارو; DDI; drug-drug interaction; β-EST; β-estradiol; HLM; human liver microsomes; IV-IVE; in vitro-in vivo extrapolation; KI; kinase inhibitor; 4MU; 4-methylumbelliferone; LAP; lapatinib; NSB; non-specific binding; PAZ; pazopanib; PRO; propofol; REG; r
In Vitro-In Vivo Extrapolation of Metabolism- and Transporter-Mediated Drug-Drug Interactions-Overview of Basic Prediction Methods
Keywords: تعامل دارو و دارو; drug interaction; cytochrome P450s; membrane transport/transporters; regulatory; guidance/guideline; ADME; absorption, distribution, metabolism and excretion; BCRP; breast cancer resistance protein; CYP; cytochrome P-450; d; induction calibration factor;
Evaluation of Renal Transporter Inhibition Using Creatinine as a Substrate In Vitro to Assess the Clinical Risk of Elevated Serum Creatinine
Keywords: تعامل دارو و دارو; renal transporter; drug interactions; in vitro-in vivo correlation; renal clearance; inhibition; AUC; area under the concentration curve; CLcr; creatinine renal clearance; Cmax; maximal total plasma concentration; Cmax,u; maximal unbound plasma concen
Determinants of Intestinal Availability for P-glycoprotein Substrate Drugs Estimated by Extensive Simulation With Mathematical Absorption Models
Keywords: تعامل دارو و دارو; drug-drug interaction; P-glycoprotein; physiologically based pharmacokinetic model; modeling and simulation; intestinal absorption; substrate drug; CLh; hepatic clearance; CLr; renal clearance; CYP3A; cytochrome P450 3A; DDI; drug-drug interaction; EQ
Short communicationInteractions between non-vitamin K oral anticoagulants and antiepileptic drugs
Keywords: تعامل دارو و دارو; AED; antiepileptic drug; AF; atrial fibrillation; DDI; drug-drug interaction; INR; International Normalized Ratio; NOAC; non-vitamin K antagonist oral anticoagulant; OAC; oral anticoagulant; VKA; vitamin-K antagonist; Atrial fibrillation; Stroke; Seizur
Quantitative analysis of pharmacokinetic profiles of verapamil and drug-drug interactions induced by a CYP inhibitor using a stable isotope-labeled compound
Keywords: تعامل دارو و دارو; 1-Aminobenzotriazole; CYP3A; Drug-drug interaction; Fa; Fg; Fh; Stable isotope; Pharmacokinetics;
Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors
Keywords: تعامل دارو و دارو; Morphine; Clopidogrel; Ticagrelor; Prasugrel; Drug-drug interaction;
An update on the role of intestinal cytochrome P450 enzymes in drug disposition
Keywords: تعامل دارو و دارو; AUC; area under concentration-time curve; CPR; NADPH-cytochrome P450 reductase; DDI; drug-drug interaction; GFJ; grapefruit juice; IECN; intestinal epithelium-specific Cpr-null; LCN; liver-specific Cpr-null; P450 (or CYP); cytochrome P450; P-gp; P-glyco
PBPK modeling and simulation in drug research and development
Keywords: تعامل دارو و دارو; PBPK; PK prediction; Absorption; Metabolism; Drug-drug interaction; Special population;
Metabolic characterization of pyrotinib in humans by ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry
Keywords: تعامل دارو و دارو; Pyrotinib; UPLC/Q-TOF MS; Metabolism; Human; CYP3A4; Drug-drug interaction;
Pharmacokinetic Interaction Between Rosuvastatin, Telmisartan, and Amlodipine in Healthy Male Korean Subjects: A Randomized, Open-label, Multiple-dose, 2-period Crossover Study
Keywords: تعامل دارو و دارو; amlodipine; drug-drug interaction; pharmacokinetic properties; rosuvastatin; telmisartan;
Insights into CYP2B6-mediated drug-drug interactions
Keywords: تعامل دارو و دارو; CAR; constitutive androstane receptor; C/EBP; CCAAT/enhancer-binding protein; CHOP; cyclophosphamide-doxorubicin-vincristine-prednisone; CITCO; (6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde-O-(3,4-dichlorobenzyl)oxime); COUP-TF; chic
Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data
Keywords: تعامل دارو و دارو; Pharmacovigilance; Association rule mining; Proportional reporting ratio; Drug-drug interaction; RxNorm; Logistic regression;
NS5A resistance leading to failure of 24-week therapy with sofosbuvir/ledipasvir and ribavirin for the treatment of hepatitis C genotype 1a infection in a HIV-1 co-infected patient
Keywords: تعامل دارو و دارو; ALT; alanine aminotransferase; AST; aspartate aminotransferase; cART; combination antiretroviral therapy; DAA; direct-acting antiviral; DDI; drug-drug interaction; EOTR; end-of-treatment response; GT; genotype; HCV; hepatitis C virus; HIV-1; human immun
Increased inhibition of cytochrome P450 3A4 with the tablet formulation of posaconazole
Keywords: تعامل دارو و دارو; Sirolimus; Posaconazole; Drug-drug interaction; Pharmacokinetics; Cytochrome P-450 CYP3A;
Mechanism-based inhibition of Alantolactone on human cytochrome P450 3A4 in vitro and activity of hepatic cytochrome P450 in mice
Keywords: تعامل دارو و دارو; Alantolactone PubChem CID: 72724; Alantolactone; CYP3A4; Human liver microsomes; Noncompetitive inhibition; Drug-drug interaction;
The effect of the introduction of a nationwide DUR system where local DUR systems are operating-The Korean experience
Keywords: تعامل دارو و دارو; Nationwide drug utilization review system; Local drug utilization review system; Drug-drug interaction; Drug-age contraindications; Drug-pregnancy contraindications;
Validated UPLC-MS/MS method for simultaneous determination of simvastatin, simvastatin hydroxy acid and berberine in rat plasma: Application to the drug-drug pharmacokinetic interaction study of simvastatin combined with berberine after oral administratio
Keywords: تعامل دارو و دارو; Simvastatin; Berberine; LC-MS-MS; Determination; Pharmacokinetics; Drug-drug interaction;
Research ArticleSTARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection
Keywords: تعامل دارو و دارو; HCV; hepatitis C virus; PI; protease inhibitor; PegIFN; peginterferon; RBV; ribavirin; SVR; sustained virologic response; DDI; drug-drug interaction; BID; twice daily; ETS; early treatment success; TD; target detected; TND; target not detected; EVR; ear
Hepatocyte spheroid culture on fibrous scaffolds with grafted functional ligands as an in vitro model for predicting drug metabolism and hepatotoxicity
Keywords: تعامل دارو و دارو; Hepatocyte spheroid; Fibrous scaffold; Functional ligand; Drug metabolism; Drug hepatotoxicity; Drug-drug interaction;
Effects of Paroxetine, a CYP2D6 Inhibitor, on the Pharmacokinetic Properties of Hydrocodone After Coadministration With a Single-entity, Once-daily, Extended-release Hydrocodone Tablet
Keywords: تعامل دارو و دارو; CYP2D6 inhibitor; drug-drug interaction; hydrocodone; hydromorphone; opioid; paroxetine; pharmacokinetics;
Pharmacokinetics of Empagliflozin and Pioglitazone After Coadministration in Healthy Volunteers
Keywords: تعامل دارو و دارو; diabetes; drug-drug interaction; SGLT2 inhibitor; thiazolidinedione;
Plasma protein binding, pharmacokinetics, tissue distribution and CYP450 biotransformation studies of fidarestat by ultra high performance liquid chromatography-high resolution mass spectrometry
Keywords: تعامل دارو و دارو; Cytochrome P450; Protein binding; UPLC/ESI/HRMS method; Drug-drug interaction; Drug-herb interaction;
Optimization of a novel series of N-phenylindoline-5-sulfonamide-based acyl CoA:monoacylglycerol acyltransferase-2 inhibitors: Mitigation of CYP3A4 time-dependent inhibition and phototoxic liabilities
Keywords: تعامل دارو و دارو; ACAT; acyl CoA:cholesterol acyltransferase; ADME; absorption, distribution, metabolism and excretion; APCI; atomospheric pressure chemical ionization; CM; chylomicron; dba; dibenzylideneacetone; CYP; cytochrome P450; DDI; drug-drug interaction; DGAT; ac
Widened QRS interval and left ventricular systolic depression after propafenone and promazine exposure
Keywords: تعامل دارو و دارو; Cardiac arrhythmias; HERG; Propafenone; Promazine; Drug-drug interaction;
Inhibition of cytochrome P450 by ethambutol in human liver microsomes
Keywords: تعامل دارو و دارو; Ethambutol; Drug-drug interaction; CYP1A2; CYP2E1; Theophylline;
Research PaperIn vitro studies of berberine metabolism and its effect of enzyme induction on HepG2 cells
Keywords: تعامل دارو و دارو; Berberine; HepG2 cell; Drug metabolism; CYP enzyme; Metabolic enzyme induction; Drug-drug interaction;
Evaluation of the Pharmacokinetic Interaction Between Ticagrelor and Venlafaxine, a Cytochrome P-450 2D6 Substrate, in Healthy Subjects
Keywords: تعامل دارو و دارو; CYP2D6; drug-drug interaction; pharmacokinetics; ticagrelor; venlafaxine;